Fabio
3.2 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Provides for pharmacy benefit management and the procurement of prescription drugs at a negotiated rate for dispensation | Provides for pharmacy benefit management and the procurement of prescription drugs to be dispensed to patients, or the administration or management of prescription drug benefits; sets forth definitions; provides for funds received by a pharmacy in trust for the health plan or provider; provides for accountability of such funds; provides for an appeals process to investigate and resolve disputes regarding multi-source generic drug pricing. | us/states/ny | New York Legislature | 2021-2022 | S 7837 | New York S 7837 (2021-2022) |
|
enacted |
|
1 | 11 | 3 | 2022-01-12 | 2022-02-24 | openstates | ocd-bill/44b1e08d-d6ac-4882-9b1a-a2376c1eae6c | http://www.nysenate.gov/legislation/bills/2021/S7837 | 2bbff41f822de397de6bcfe2e0a205a32c6503ab4186e634dca7d28c139029a8 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
New York S 7837 (2021-2022) — Provides for pharmacy benefit management and the procurement of prescription drugs at a negotiated rate for dispensation
Provides for pharmacy benefit management and the procurement of prescription drugs to be dispensed to patients, or the administration or management of prescription drug benefits; sets forth definitions; provides for funds received by a pharmacy in trust for the health plan or provider; provides for accountability of such funds; provides for an appeals process to investigate and resolve disputes regarding multi-source generic drug pricing.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- S7837 (committee substitute) — source
Votes
- Floor Vote — 62–1 (pass) · upper
- Assembly Vote — 144–0 (pass) · lower
- Rules Vote — 20–1 (pass) · upper
Sponsors
- BRESLIN — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2022-01-12 REFERRED TO RULES
referral-committee - 2022-01-18 ORDERED TO THIRD READING CAL.195
- 2022-01-19 PASSED SENATE
passage - 2022-01-19 DELIVERED TO ASSEMBLY
- 2022-01-19 REFERRED TO HEALTH
referral-committee - 2022-02-14 SUBSTITUTED FOR A8838
- 2022-02-14 ORDERED TO THIRD READING CAL.403
- 2022-02-14 PASSED ASSEMBLY
passage - 2022-02-14 RETURNED TO SENATE
- 2022-02-24 DELIVERED TO GOVERNOR
executive-receipt - 2022-02-24 SIGNED CHAP.128
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/44b1e08d-d6ac-4882-9b1a-a2376c1eae6c. Confidence: reported (aggregated from official New York legislature records).